We will continue to work diligently to ensure we provide you with the most current information here.
Roche's diagnostic response to COVID-19
Real-time RT-PCR test
Detecting SARS-CoV-2 in currently infected patients with high sensitivity
The cobas® SARS-CoV-2 Test is a real-time RT-PCR test intended for the qualitative detection of SARS-CoV-2 in nasopharyngeal and oropharyngeal swab samples from patients.
This test can be run on Roche’s fully automated cobas® 6800 and cobas® 8800 Systems under Emergency Use Authorization.
Detecting a patient’s immune response to SARS CoV-2 with high specificity
Elecsys® Anti‑SARS‑CoV‑2 is an immunoassay intended for qualitative detection of antibodies to SARS‑CoV‑2 in human serum and plasma (K2‑EDTA, K3‑EDTA, Li‑heparin). The test is intended for use as an aid in identifying individuals with an adaptive immune response to SARS‑CoV‑2, indicating recent or prior infection.
The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers.